Electromed Inc
$ 42.19
0.36%
07 Aug - close price
- Market Cap 346,686,000 USD
- Current Price $ 42.19
- High / Low $ 42.65 / 41.40
- Stock P/E 36.09
- Book Value 5.94
- EPS 1.16
- Next Earning Report 2026-08-25
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.15 %
- ROE 0.22 %
- 52 Week High 47.40
- 52 Week Low 18.55
About
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation (HFCWO) therapy in lung care for patients of all ages in the United States. and internationally. The company is headquartered in New Prague, Minnesota.
Analyst Target Price
$40.33
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-12 | 2026-02-10 | 2025-11-12 | 2025-08-26 | 2025-05-13 | 2025-02-11 | 2024-11-12 | 2024-08-27 | 2024-05-07 | 2024-02-13 | 2023-11-07 | 2023-08-22 |
| Reported EPS | 0.3473 | 0.32 | 0.25 | 0.25 | 0.21 | 0.22 | 0.16 | 0.2 | 0.17 | 0.19 | 0.02 | 0.12 |
| Estimated EPS | 0.2375 | 0.26 | 0.21 | 0.22 | 0.2 | 0.18 | 0.03 | 0.14 | 0.13 | 0.1 | 0.1 | 0.13 |
| Surprise | 0.1098 | 0.06 | 0.04 | 0.03 | 0.01 | 0.04 | 0.13 | 0.06 | 0.04 | 0.09 | -0.08 | -0.01 |
| Surprise Percentage | 46.2316% | 23.0769% | 19.0476% | 13.6364% | 5% | 22.2222% | 433.3333% | 42.8571% | 30.7692% | 90% | -80% | -7.6923% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-25 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.32 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ELMD
2026-08-03 11:40:02
This article provides financial information for Electromed, Inc. (AMEX:ELMD), specifically focusing on its enterprise value to revenue forward metric. The content highlights the company's stock on the NYSE American exchange and indicates that the market was closed with no trades at the time of publication. It serves as a brief financial snapshot for potential investors.
2026-07-28 06:39:10
Electromed, Inc. (AMEX: ELMD) generated $64.00 million USD in revenue last year. The Commercial segment was its top-performing segment, contributing $29.13 million USD, an increase from $24.21 million USD in the prior year. The United States market was the largest contributor to revenue at $63.74 million USD.
2026-07-27 21:11:25
This article presents the cash flow statement for Electromed Inc (ELMD), detailing its operating, investing, and financing cash flows over many fiscal quarters. It breaks down various components like net income from continuing operations, capital expenditures, and free cash flow. The article also includes a FAQ section defining different types of cash flows and providing specific figures for Electromed Inc.
2026-07-27 10:10:32
This article provides a detailed revenue breakdown for Electromed Inc (ELMD) by business segment, updated as of April 6. The company's revenue is primarily driven by "Home Care-Commercial" and "Home Care-Medicare" services. Key financial metrics such as market capitalization and P/E ratio are also included.
2026-07-27 09:10:32
Electromed Inc. (ELMD) develops and sells airway clearance therapy products, notably the SmartVest Airway Clearance System, for patients with compromised pulmonary function. The company's detailed profile includes financial data like a market cap of $330.48M and a P/E TTM of 32.74, alongside information on its executives and key shareholders. In Q1 2026, the Home Care-Commercial business was its largest revenue source, contributing $7.99M, or 42.26% of total revenue.
2026-07-24 20:11:15
The article provides an overview of Electromed Inc's (ELMD) institutional confidence score, which is currently 5.00, ranking 108th in its industry. Institutional shareholding stands at 58.36%, with a slight quarter-over-quarter decrease. James Simons is identified as the largest institutional shareholder, and a list of other significant institutional shareholders and their recent activity is included.
